In a filing, Cardio Diagnostics Holdings Inc revealed its Chief Medical Officer Philibert Robert acquired Company’s shares for reported $9763.0 on Sep 06 ’24. In the deal valued at $0.29 per share,34,075 shares were bought. As a result of this transaction, Philibert Robert now holds 1,683,867 shares worth roughly $0.72 million.
Then, Dogan Meeshanthini bought 68,965 shares, generating $20,000 in total proceeds. Upon buying the shares at $0.29, the Chief Technology Officer now owns 197,310 shares.
Before that, Dogan Meeshanthini bought 68,965 shares. Cardio Diagnostics Holdings Inc shares valued at $20,000 were divested by the Chief Executive Officer at a price of $0.29 per share. As a result of the transaction, Dogan Meeshanthini now holds 1,683,867 shares, worth roughly $0.72 million.
Price Performance Review of CDIO
On Tuesday, Cardio Diagnostics Holdings Inc [NASDAQ:CDIO] saw its stock fall -9.12% to $0.43. Over the last five days, the stock has lost -6.17%. Cardio Diagnostics Holdings Inc shares have fallen nearly -53.38% since the year began. Nevertheless, the stocks have fallen -38.48% over the past one year. While a 52-week high of $1.77 was reached on 01/06/25, a 52-week low of $0.19 was recorded on 04/07/25. SMA at 50 days reached $0.4148, while 200 days put it at $0.4490.
Levels Of Support And Resistance For CDIO Stock
The 24-hour chart illustrates a support level at 0.4065, which if violated will result in even more drops to 0.3855. On the upside, there is a resistance level at 0.4620. A further resistance level may holdings at 0.4965. The Relative Strength Index (RSI) on the 14-day chart is 50.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0090, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 69.36%. Stochastics %K at 37.15% indicates the stock is a holding.
